Skip to ContentSkip to Navigation
About us Practical matters How to find us A.M.H. Soliman

Publications

Characterization of Lipopolysaccharide Effects on LRRK2 Signaling in RAW Macrophages

Characterization and therapeutic targeting of Parkinson’s-related LRRK2

LRRK2 protects immune cells against erastin-induced ferroptosis

Nanobodies as allosteric modulators of Parkinson's disease-associated LRRK2

Allosteric Inhibition of Parkinson's-Linked LRRK2 by Constrained Peptides

Nanobodies as allosteric modulators of Parkinson’s disease-associated LRRK2

Allosteric inhibition of LRRK2, where are we now